Aedifica and Cofinimmo: Exchange offer to start tomorrow / Alfen: Preview: new year, new chances / BAM Group: Nice add-on in the Dutch housing market / dsm-firmenich: Givaudan 2026 guidance read-across / Heijmans: Preview: 2025F was the cat's meow / Melexis: 4Q25 preview, towards a cyclical recovery / TomTom: Preview 4Q25, look beyond 2026 / Van Lanschot Kempen: Small UK Fiduciary mandate, second of the month though
Last year, we placed dsm-firmenich on our Benelux Favourites list because we believed that a clean disposal of the Animal Nutrition and Health (ANH) division would catalyse a re-rating towards the EBITDA multiples enjoyed by Symrise and Givaudan. Unfortunately, the company has been unable to meet the disposal timetable or its initial EBITDA guidance for 2025, and we now conclude that a disposal of ANH is unlikely to be clean or at a particularly good valuation. Although we still expect a re-rati...
dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer Press Release dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer Kaiseraugst (Switzerland), Maastricht (Netherlands), January 14, 2026 dsm-firmenich, the leading innovator in nutrition, health, and beauty, today announces the appointment of Nikeisha van Sleeuwen as Chief Human Resources Officer (CHRO). Effective April 1, 2026, she will report directly to Dimitri de Vreeze, dsm-firmenich’s Chief Executive Officer, and will serve as a member of the Executive Committee. She succeeds Miek...
We update the performance of our ING Benelux Favourites list as well as all valuation and ranking tables for our coverage universe. Performance on the front page is dated from the 19 September 2025, while historical performance is included on the second page. The methodology for our favourites selection is based on a bottom-up approach with a focus on absolute performance with clear near-term triggers. It is a rolling list, ie, stocks can enter/exit whenever we think opportune.
dsm-firmenich completes €1.08 billion share repurchase program Press Release dsm-firmenich completes €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), December 2, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces it has completed its share repurchase program for a value of €1.08 billion, ahead of the expected completion at the end of January 2026. On February 13, 2025, dsm-firmenich announced its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital. dsm-firme...
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), November 25, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a total...
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), November 18, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a total...
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), November 11, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a total...
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), November 4, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares for a total ...
AB InBev: The interim is back. Arcadis: Slow return to organic growth, FCF disappoints. Ayvens: Keeping its promise. dsm-firmenich: Waiting for Godot. D'Ieteren: Boyd prelim 3Q25, $1.3bn M&A deal, NYSE listing, $780m capital increase. Flow Traders: Down but not out. Ontex: FY25F guidance confirmed despite a modestly softer 3Q25. Recticel: Weak 3Q25 but comforting outlook. Shell plc: Solid story with cash continuing to come in strongly. TKH Group: Preview - subsea remains in foc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.